These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

208 related items for PubMed ID: 11300026

  • 1. [Raltitrexed in colorectal cancer].
    Comandone A, Oliva C, Dal Canton O, Boglione A, Bergnolo P.
    Tumori; 2001; 87(1 Suppl 1):S53-4. PubMed ID: 11300026
    [No Abstract] [Full Text] [Related]

  • 2. The use of raltitrexed (tomudex) in a patient with 5-fluorouracil induced myocardial ischaemia.
    Nutting C, Folkes A.
    Clin Oncol (R Coll Radiol); 1999; 11(1):66. PubMed ID: 10194593
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Raltitrexed. A review of its pharmacological properties and clinical efficacy in the management of advanced colorectal cancer.
    Gunasekara NS, Faulds D.
    Drugs; 1998 Mar; 55(3):423-35. PubMed ID: 9530547
    [Abstract] [Full Text] [Related]

  • 5. Clinical trials referral resource. Clinical trials with tomudex.
    Sorensen JM, Cheson BD, Phillips PH.
    Oncology (Williston Park); 1996 Jul; 10(7):1041-2. PubMed ID: 8837120
    [No Abstract] [Full Text] [Related]

  • 6. Targeting thymidylate synthase in colorectal cancer: critical re-evaluation and emerging therapeutic role of raltitrexed.
    Avallone A, Di Gennaro E, Silvestro L, Iaffaioli VR, Budillon A.
    Expert Opin Drug Saf; 2014 Jan; 13(1):113-29. PubMed ID: 24093908
    [Abstract] [Full Text] [Related]

  • 7. Thymidylate synthase inhibition, a dead end?
    Herrmann R.
    Eur J Cancer; 1995 Nov; 31A(12):1919-20. PubMed ID: 8562141
    [No Abstract] [Full Text] [Related]

  • 8. Results of a European multicentre trial of Tomudex versus 5-FU/high dose LV (Machover regimen).
    Cocconi G.
    Tumori; 1997 Nov; 83(1 Suppl):S72. PubMed ID: 9154075
    [No Abstract] [Full Text] [Related]

  • 9. [Oxaliplatin: combinations with thymidylate synthetase inhibitors: two consecutive phase II studies].
    Martoni A, Mini E, Pinto C, Gentile A, Mazzei T.
    Tumori; 2001 Nov; 87(6):A25-6. PubMed ID: 11995701
    [No Abstract] [Full Text] [Related]

  • 10. Efficacy and tolerability of a new inhibitor of thymidylate synthase: 'Tomudex' (raltitrexed).
    Cunningham D.
    Tumori; 1997 Nov; 83(1 Suppl):S70-1. PubMed ID: 9154074
    [No Abstract] [Full Text] [Related]

  • 11. Phase II study of raltitrexed (Tomudex) in chemotherapy-pretreated patients with advanced colorectal cancer. Tomudex Cooperative Study Group.
    Sato A, Kurihara M, Horikoshi N, Aiba K, Kikkawa N, Shirouzu K, Mitachi Y, Sakata Y, Wakui A.
    Anticancer Drugs; 1999 Sep; 10(8):741-8. PubMed ID: 10573207
    [Abstract] [Full Text] [Related]

  • 12. Raltitrexed combined with bevacizumab in heavily pretreated metastatic colorectal cancer.
    Cheng K, Chen Y, Li LH, Liu JY.
    J Cancer Res Ther; 2013 Sep; 9(4):727-9. PubMed ID: 24518728
    [Abstract] [Full Text] [Related]

  • 13. Drug resistance in colon cancer.
    Gorlick R, Bertino JR.
    Semin Oncol; 1999 Dec; 26(6):606-11. PubMed ID: 10606253
    [Abstract] [Full Text] [Related]

  • 14. New developments in cancer treatment with the novel thymidylate synthase inhibitor raltitrexed ('Tomudex').
    Blackledge G.
    Br J Cancer; 1998 Dec; 77 Suppl 2(Suppl 2):29-37. PubMed ID: 9579853
    [Abstract] [Full Text] [Related]

  • 15. Raltitrexed, a new drug for advanced colorectal cancer.
    Mead GM.
    Lancet; 1996 Jun 08; 347(9015):1568-9. PubMed ID: 8667859
    [No Abstract] [Full Text] [Related]

  • 16. Patterns of elevation of plasma 2'-deoxyuridine, a surrogate marker of thymidylate synthase (TS) inhibition, after administration of two different schedules of 5-fluorouracil and the specific TS inhibitors raltitrexed (Tomudex) and ZD9331.
    Ford HE, Mitchell F, Cunningham D, Farrugia DC, Hill ME, Rees C, Calvert AH, Judson IR, Jackman AL.
    Clin Cancer Res; 2002 Jan 08; 8(1):103-9. PubMed ID: 11801545
    [Abstract] [Full Text] [Related]

  • 17. Raltitrexed treatment promotes systemic inflammatory reaction in patients with colorectal carcinoma.
    Osterlund P, Orpana A, Elomaa I, Repo H, Joensuu H.
    Br J Cancer; 2002 Sep 09; 87(6):591-9. PubMed ID: 12237767
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Raltitrexed, a novel folate-based thymidylate synthase inhibitor, for the treatment of acute leukemia: is this drug active against acute myelogenous leukemia?
    Takemura Y, Kobayashi H, Miyachi H.
    Int J Hematol; 2000 Jul 09; 72(1):112-4. PubMed ID: 10979221
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.